Home » MILLIPORE TO BUY SEROLOGICALS FOR $1.4B
MILLIPORE TO BUY SEROLOGICALS FOR $1.4B
Millipore Corp. on Tuesday said it agreed to acquire Serologicals Corp. for about $1.4 billion in cash and assumed debt, in a deal that would strengthen its relationships with biotechnology and pharmaceutical customers.
Business Week
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May